drugset / Trial / NCT00825370

Protocolized vs Discretionary Use of Opioids in Acute Pain

NCT00825370

Phase 3 Completed 350 enrolled Montefiore Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

We are testing whether patients who received protocolized pain management (1 mg of IV hydromorphone followed by an additional 1 mg Intravenous (IV) hydromorphone 15 minutes later if the patients wants more) will have better pain relief and no more adverse events than patients receiving discretionary care, in which the patients receives whatever IV opioid the treating physician wants to give, in whatever dose.

Timeline

Start
2008-10
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified 1 mg Intravenous

Indications

No indication recorded.